From the category archives:

Avandia

“These Data Should Not See the Light of Day”

by Dr. Stephen Parker (Article selection and Commentary) on July 24, 2010

The Avandia story — science at the wounded heart of medicine By Kate Scannell 07/24/2010 THE TROUBLING story about the diabetes drug Avandia concerns everyone — not “just” the millions of diabetic patients who have taken it. It concerns everyone because it provides an instructive and cautionary tale about prescription drug evaluation and marketing in [...]

{ 0 comments }

Avandia and Heart Attacks: Big Pharma, FDA Cover-Up, as Usual

by heartcurrents on February 22, 2010

CNN) — The diabetes drug Avandia is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, according to a Senate committee report released Saturday. The 334-page report by the Senate Finance Committee also criticized the Food and Drug Administration, [...]

{ 0 comments }